ProCE Banner Activity

Overview of EGFR-Mutated NSCLC and Pharmacology of EGFR TKIs

Slideset Download
In this downloadable slideset, Val R. Adams, PharmD, FCCP, BCOP, reviews the landscape of EGFR mutations in advanced NSCLC and the pharmacology of EGFR tyrosine kinase inhibitors used in this setting.

Released: March 02, 2018

Expiration: March 01, 2019

No longer available for credit.

Share

Faculty

Val R. Adams

Val R. Adams, PharmD, FCCP, BCOP

Associate Professor
Department of Pharmacy Practice and Science
University of Kentucky
Lexington, Kentucky

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Val R. Adams, PharmD, FCCP, BCOP

Associate Professor
Department of Pharmacy Practice and Science
University of Kentucky
Lexington, Kentucky